Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation.
暂无分享,去创建一个
Richard T. Lee | L. Rubin | Sean M. Buchanan | A. Wagers | P. Ganz | R. G. Walker | T. B. Thompson | T. Poggioli | Lida Katsimpardi | Juhyun Oh | S. Wattrus | B. Heidecker | Y. Fong | T. Thompson | Richard T. Lee
[1] M. Franti,et al. Crystal structure of human GDF11. , 2016, Acta crystallographica. Section F, Structural biology communications.
[2] T. Mueller,et al. Structural insights into BMP receptors: Specificity, activation and inhibition. , 2016, Cytokine & growth factor reviews.
[3] P. López-Jaramillo. The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions. , 2016, The Journal of nutrition.
[4] Richard T. Lee,et al. Circulating Growth Differentiation Factor 11/8 Levels Decline With Age. , 2016, Circulation research.
[5] E. McNally. Questions and Answers About Myostatin, GDF11, and the Aging Heart. , 2016, Circulation research.
[6] David G. Sterling,et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts. , 2015, European heart journal.
[7] M. Jensen,et al. Targeting senescent cells enhances adipogenesis and metabolic function in old age , 2015, eLife.
[8] S. Houser,et al. GDF11 does not rescue aging-related pathological hypertrophy. , 2015, Circulation research.
[9] S. Carmichael,et al. GDF10 Is a Signal for Axonal Sprouting and Functional Recovery after Stroke , 2015, Nature Neuroscience.
[10] B. Spiegelman,et al. Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. , 2015, Cell metabolism.
[11] W. Mitch,et al. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues , 2015, International Journal of Obesity.
[12] B. D. Rodgers,et al. Reduced Circulating GDF11 Is Unlikely Responsible for Age-Dependent Changes in Mouse Heart, Muscle, and Brain. , 2015, Endocrinology.
[13] D. Nemet,et al. Frequency of the MSTN Lys(K)-153Arg(R) polymorphism among track & field athletes and swimmers. , 2015, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[14] BerdeliAfig,et al. Myostatin Gene Polymorphism in an Elderly Sarcopenic Turkish Population , 2015 .
[15] H. R. Bergen,et al. Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay , 2015, Skeletal Muscle.
[16] I. Clay,et al. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. , 2015, Cell metabolism.
[17] J. Massagué,et al. Structural determinants of Smad function in TGF-β signaling. , 2015, Trends in biochemical sciences.
[18] Eric P. Hoffman,et al. Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy , 2015, Proceedings of the National Academy of Sciences.
[19] Konstantin I Bakhurin,et al. Haploinsufficiency of myostatin protects against aging-related declines in muscle function and enhances the longevity of mice , 2015, Aging cell.
[20] David G. Sterling,et al. LOW LEVELS OF GROWTH DIFFERENTIATION FACTOR 11 AND HIGH LEVELS OF ITS INHIBITOR FOLLISTATIN-LIKE 3 ARE ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES IN HUMANS , 2015 .
[21] T. Borchardt,et al. Myostatin induces interstitial fibrosis in the heart via TAK1 and p38 , 2015, Cell and Tissue Research.
[22] Yun‐Sil Lee,et al. Alternative Binding Modes Identified for Growth and Differentiation Factor-associated Serum Protein (GASP) Family Antagonism of Myostatin* , 2015, The Journal of Biological Chemistry.
[23] H. Sweeney,et al. Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy. , 2015, Biochemical and biophysical research communications.
[24] L. Buday,et al. K153R polymorphism in myostatin gene increases the rate of promyostatin activation by furin , 2015, FEBS letters.
[25] Y. Sunada,et al. Identification of the minimum peptide from mouse myostatin prodomain for human myostatin inhibition. , 2015, Journal of medicinal chemistry.
[26] T. Borchardt,et al. Myostatin Regulates Energy Homeostasis in the Heart and Prevents Heart Failure ” , 2015 .
[27] N. Perrimon,et al. Intertissue control of the nucleolus via a myokine-dependent longevity pathway. , 2014, Cell reports.
[28] T. Wyss-Coray,et al. ALK5-dependent TGF-β signaling is a major determinant of late stage adult neurogenesis , 2014, Nature Neuroscience.
[29] Richard T. Lee,et al. Restoring Systemic GDF11 Levels Reverses Age-Related Dysfunction in Mouse Skeletal Muscle , 2014, Science.
[30] Richard T. Lee,et al. Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors , 2014, Science.
[31] Danielle A. Simmons,et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice , 2014, Nature Medicine.
[32] R. Paulson. Targeting a new regulator of erythropoiesis to alleviate anemia , 2014, Nature Medicine.
[33] A. Grinberg,et al. Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis , 2014, Nature Medicine.
[34] A. Fricot,et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia , 2014, Nature Medicine.
[35] L. Wen,et al. The A55T and K153R polymorphisms of MSTN gene are associated with the strength training-induced muscle hypertrophy among Han Chinese men , 2014, Journal of sports sciences.
[36] N. LeBrasseur,et al. Myostatin and Sarcopenia: Opportunities and Challenges - A Mini-Review , 2014, Gerontology.
[37] S. Brachat,et al. An Antibody Blocking Activin Type II Receptors Induces Strong Skeletal Muscle Hypertrophy and Protects from Atrophy , 2013, Molecular and Cellular Biology.
[38] H. Heuft,et al. Highly Specific Detection of Myostatin Prodomain by an Immunoradiometric Sandwich Assay in Serum of Healthy Individuals and Patients , 2013, PloS one.
[39] T. Rando,et al. Numb-deficient satellite cells have regeneration and proliferation defects , 2013, Proceedings of the National Academy of Sciences.
[40] Yun‐Sil Lee,et al. Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 , 2013, Proceedings of the National Academy of Sciences.
[41] L. Patthy,et al. Latent myostatin has significant activity and this activity is controlled more efficiently by WFIKKN1 than by WFIKKN2 , 2013, The FEBS journal.
[42] Richard T. Lee,et al. Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy , 2013, Cell.
[43] S. Kuang,et al. Myostatin knockout drives browning of white adipose tissue through activating the AMPK‐PGC1α‐Fndc5 pathway in muscle , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] A. Datta-Mannan,et al. An Engineered Human Follistatin Variant: Insights into the Pharmacokinetic and Pharmocodynamic Relationships of a Novel Molecule with Broad Therapeutic Potential , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[45] A. Lucia,et al. Genes, physical fitness and ageing , 2013, Ageing Research Reviews.
[46] G. Ricevuti,et al. Association of the K153R polymorphism in the myostatin gene and extreme longevity , 2013, AGE.
[47] P. Carmeliet,et al. Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin , 2012, Proceedings of the National Academy of Sciences.
[48] S. Falconer,et al. Growth and differentiation factor-11 is developmentally regulated in skeletal muscle and inhibits myoblast differentiation , 2012 .
[49] B. D. Rodgers,et al. Myostatin inhibits myosatellite cell proliferation and consequently activates differentiation: evidence for endocrine-regulated transcript processing. , 2012, The Journal of endocrinology.
[50] J. Massagué. TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.
[51] N. Rosenthal,et al. Follistatin-Like 3 Mediates Paracrine Fibroblast Activation by Cardiomyocytes , 2012, Journal of Cardiovascular Translational Research.
[52] S. Jain,et al. Association of the Myostatin Gene with Obesity, Abdominal Obesity and Low Lean Body Mass and in Non-Diabetic Asian Indians in North India , 2012, PloS one.
[53] M. Matzuk,et al. Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway , 2012, Proceedings of the National Academy of Sciences.
[54] James M. Allen,et al. Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin , 2012, The Journal of cell biology.
[55] F. Muntoni,et al. Donor Satellite Cell Engraftment is Significantly Augmented When the Host Niche is Preserved and Endogenous Satellite Cells are Incapacitated , 2012, Stem cells.
[56] I. Komuro,et al. Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes , 2012, Cell.
[57] H. Keutmann,et al. Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism. , 2012, Molecular endocrinology.
[58] P. Hoen,et al. Cell‐type specific regulation of myostatin signaling , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[59] L. Kunkel,et al. β4 Integrin Marks Interstitial Myogenic Progenitor Cells in Adult Murine Skeletal Muscle , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[60] Chandramohan Kattamuri,et al. Structure of Myostatin·Follistatin-like 3 , 2011, The Journal of Biological Chemistry.
[61] N. Frangogiannis,et al. Transforming growth factor (TGF)-β signaling in cardiac remodeling. , 2011, Journal of molecular and cellular cardiology.
[62] C. Harrison,et al. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands , 2011, Growth factors.
[63] H. Sweeney,et al. Myostatin Is Elevated in Congenital Heart Disease and After Mechanical Unloading , 2011, PloS one.
[64] T. Walz,et al. Latent TGF-β structure and activation , 2011, Nature.
[65] D. Kass,et al. Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload. , 2011, The Journal of clinical investigation.
[66] C. Ward,et al. Losartan Restores Skeletal Muscle Remodeling and Protects Against Disuse Atrophy in Sarcopenia , 2011, Science Translational Medicine.
[67] V. Fuster,et al. Cellular Senescence, Vascular Disease, and Aging: Part 2 of a 2-Part Review Clinical Vascular Disease in the Elderly , 2011, Circulation.
[68] Takako Sasaki,et al. Prodomains of transforming growth factor beta (TGFbeta) superfamily members specify different functions: extracellular matrix interactions and growth factor bioavailability. , 2011, The Journal of biological chemistry.
[69] A. Lucia,et al. The K153R Polymorphism in the Myostatin Gene and Muscle Power Phenotypes in Young, Non-Athletic Men , 2011, PloS one.
[70] Yingtang Shi,et al. Gdf11 Facilitates Temporal Progression of Neurogenesis in the Developing Spinal Cord , 2011, The Journal of Neuroscience.
[71] Kazuto Nakamura,et al. Cardiac Myocyte-specific Ablation of Follistatin-like 3 Attenuates Stress-induced Myocardial Hypertrophy* , 2011, The Journal of Biological Chemistry.
[72] A. Boyle,et al. The aging heart and post-infarction left ventricular remodeling. , 2011, Journal of the American College of Cardiology.
[73] L. Patthy,et al. WFIKKN1 and WFIKKN2 bind growth factors TGFβ1, BMP2 and BMP4 but do not inhibit their signalling activity , 2010, The FEBS journal.
[74] A. Mcpherron. METABOLIC FUNCTIONS OF MYOSTATIN AND GDF11. , 2010, Immunology, endocrine & metabolic agents in medicinal chemistry.
[75] Tracy R. Keeney,et al. Aptamer-based multiplexed proteomic technology for biomarker discovery , 2010, PloS one.
[76] C. Petrilli,et al. Myostatin activation in patients with advanced heart failure and after mechanical unloading , 2010, European journal of heart failure.
[77] A. Lucia,et al. The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan , 2010, AGE.
[78] A. Hinck,et al. Ternary Complex of Transforming Growth Factor-β1 Reveals Isoform-specific Ligand Recognition and Receptor Recruitment in the Superfamily* , 2010, The Journal of Biological Chemistry.
[79] S. Welle,et al. Genetic Deletion of Myostatin From the Heart Prevents Skeletal Muscle Atrophy in Heart Failure , 2010, Circulation.
[80] K. Tsuchida,et al. Activin A and Follistatin-Like 3 Determine the Susceptibility of Heart to Ischemic Injury , 2009, Circulation.
[81] C. Murry,et al. Myostatin represses physiological hypertrophy of the heart and excitation–contraction coupling , 2009, The Journal of physiology.
[82] M. Mittleman,et al. Effects of myostatin deletion in aging mice , 2009, Aging cell.
[83] T. B. Thompson,et al. The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding , 2009, The EMBO journal.
[84] S. Hatakeyama,et al. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.
[85] T. M. Bradley,et al. Overexpression of follistatin in trout stimulates increased muscling. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.
[86] K. Patel,et al. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity , 2009, Proceedings of the National Academy of Sciences.
[87] Barbara Gayraud-Morel,et al. Skeletal muscle as a paradigm for regenerative biology and medicine. , 2009, Regenerative medicine.
[88] Se-Jin Lee,et al. Redundancy of myostatin and growth/differentiation factor 11 function , 2009, BMC Developmental Biology.
[89] Xuan Chen,et al. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. , 2008, Molecular endocrinology.
[90] Chandramohan Kattamuri,et al. The Structure of FSTL3·Activin A Complex , 2008, Journal of Biological Chemistry.
[91] N. Rosenthal,et al. Expression of follistatin-related genes is altered in heart failure. , 2008, Endocrinology.
[92] L. Patthy,et al. Both WFIKKN1 and WFIKKN2 Have High Affinity for Growth and Differentiation Factors 8 and 11* , 2008, Journal of Biological Chemistry.
[93] A. Goldberg,et al. Identification of a Novel Pool of Extracellular Pro-myostatin in Skeletal Muscle* , 2008, Journal of Biological Chemistry.
[94] A. Hinck,et al. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. , 2008, Molecular cell.
[95] Barbara Gayraud-Morel,et al. A role for the myogenic determination gene Myf5 in adult regenerative myogenesis. , 2007, Developmental biology.
[96] C. Keller,et al. Increased Wnt Signaling During Aging Alters Muscle Stem Cell Fate and Increases Fibrosis , 2007, Science.
[97] D. Freyssenet,et al. Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression. , 2007, Endocrinology.
[98] C. Bustamante,et al. A Mutation in the Myostatin Gene Increases Muscle Mass and Enhances Racing Performance in Heterozygote Dogs , 2007, PLoS genetics.
[99] T. Abraham,et al. Myostatin does not regulate cardiac hypertrophy or fibrosis , 2007, Neuromuscular Disorders.
[100] Susan C. Brown,et al. Lack of myostatin results in excessive muscle growth but impaired force generation , 2007, Proceedings of the National Academy of Sciences.
[101] E. Rosen,et al. FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults , 2007, Proceedings of the National Academy of Sciences.
[102] Zhenguo Wu,et al. Myostatin Induces Cyclin D1 Degradation to Cause Cell Cycle Arrest through a Phosphatidylinositol 3-Kinase/AKT/GSK-3β Pathway and Is Antagonized by Insulin-like Growth Factor 1* , 2006, Journal of Biological Chemistry.
[103] L. Klaman,et al. Administration of myostatin does not alter fat mass in adult mice , 2006, Diabetes, obesity & metabolism.
[104] L. Mucke,et al. Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. , 2006, The Journal of clinical investigation.
[105] P. Serup,et al. Analysis of pancreatic endocrine development in GDF11‐deficient mice , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[106] Jeh-Ping Liu. The function of growth/differentiation factor 11 (Gdf11) in rostrocaudal patterning of the developing spinal cord , 2006, Development.
[107] A. Mukherjee,et al. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. , 2006, Endocrinology.
[108] P. Lepage,et al. Identification of CD109 as part of the TGF‐β receptor system in human keratinocytes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[109] S. Choe,et al. Structure of the ternary signaling complex of a TGF-β superfamily member , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[110] C. Ibáñez,et al. Synergistic interaction between Gdf1 and Nodal during anterior axis development. , 2006, Developmental biology.
[111] Raymond T Chung,et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.
[112] T. Nishimura,et al. Decorin binds myostatin and modulates its activity to muscle cells. , 2006, Biochemical and biophysical research communications.
[113] Yan Chen,et al. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. , 2006, Cancer research.
[114] Robert W Cook,et al. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. , 2005, Developmental cell.
[115] C. Woolf,et al. Repulsive Guidance Molecule (RGMa), a DRAGON Homologue, Is a Bone Morphogenetic Protein Co-receptor* , 2005, Journal of Biological Chemistry.
[116] D. Greenspan,et al. GDF11 Forms a Bone Morphogenetic Protein 1-Activated Latent Complex That Can Modulate Nerve Growth Factor-Induced Differentiation of PC12 Cells , 2005, Molecular and Cellular Biology.
[117] B. Langley,et al. Proteolytic processing of myostatin is auto-regulated during myogenesis. , 2005, Developmental biology.
[118] M. Matzuk,et al. GDF11 Controls the Timing of Progenitor Cell Competence in Developing Retina , 2005, Science.
[119] A. Brivanlou,et al. DRAGON, a Bone Morphogenetic Protein Co-receptor* , 2005, Journal of Biological Chemistry.
[120] Zhijian Lu,et al. Regulation of GDF-8 signaling by the p38 MAPK. , 2005, Cellular signalling.
[121] I. Weissman,et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment , 2005, Nature.
[122] L. Whittemore,et al. Loss of myostatin expression alters fiber‐type distribution and expression of myosin heavy chain isoforms in slow‐ and fast‐type skeletal muscle , 2005, Muscle & nerve.
[123] Xueying Gu,et al. GDF11 modulates NGN3+ islet progenitor cell number and promotes β-cell differentiation in pancreas development , 2004, Development.
[124] D. Rifkin,et al. Integrin αVβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 , 2004, The Journal of cell biology.
[125] K. Patel,et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. , 2004, Developmental biology.
[126] W. Sebald,et al. Molecular recognition of BMP-2 and BMP receptor IA , 2004, Nature Structural &Molecular Biology.
[127] L. Liang,et al. Characterization and identification of the inhibitory domain of GDF-8 propeptide. , 2004, Biochemical and biophysical research communications.
[128] E. Masliah,et al. Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.
[129] W. N. Pappano,et al. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[130] J. Wrana,et al. Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.
[131] Seumas McCroskery,et al. Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.
[132] M. Rudnicki,et al. Wnt Signaling Induces the Myogenic Specification of Resident CD45+ Adult Stem Cells during Muscle Regeneration , 2003, Cell.
[133] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[134] R. Hewick,et al. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. , 2003, Molecular endocrinology.
[135] Se-Jin Lee,et al. Regulation of metanephric kidney development by growth/differentiation factor 11. , 2003, Developmental biology.
[136] T. Jardetzky,et al. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.
[137] Anne L. Calof,et al. Autoregulation of Neurogenesis by GDF11 , 2003, Neuron.
[138] R. Hewick,et al. The Myostatin Propeptide and the Follistatin-related Gene Are Inhibitory Binding Proteins of Myostatin in Normal Serum* , 2002, The Journal of Biological Chemistry.
[139] L. Ferrucci,et al. Myostatin Polymorphisms and Age‐Related Sarcopenia in the Italian Population , 2002, Journal of the American Geriatrics Society.
[140] T. Zimmers,et al. Induction of Cachexia in Mice by Systemically Administered Myostatin , 2002, Science.
[141] A. Ebert,et al. Cripto-1 Activates Nodal- and ALK4-Dependent and -Independent Signaling Pathways in Mammary Epithelial Cells , 2002, Molecular and Cellular Biology.
[142] M. Azain,et al. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. , 2002, Biochemical and biophysical research communications.
[143] Se-Jin Lee,et al. Suppression of body fat accumulation in myostatin-deficient mice. , 2002, The Journal of clinical investigation.
[144] T. Jessell,et al. Assigning the Positional Identity of Spinal Motor Neurons Rostrocaudal Patterning of Hox-c Expression by FGFs, Gdf11, and Retinoids , 2001, Neuron.
[145] L. Fried,et al. Polymorphic Variation in the Human Myostatin (GDF‐8) Gene and Association with Strength Measures in the Women's Health and Aging Study II Cohort , 2001, Journal of the American Geriatrics Society.
[146] Se-Jin Lee,et al. Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[147] L. Patthy,et al. A human protein containing multiple types of protease-inhibitory modules , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[148] V. Rosen,et al. Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb. , 2001, Developmental biology.
[149] Quazi Shakey,et al. Gdf-8 Propeptide Binds to GDF-8 and Antagonizes Biological Activity by Inhibiting GDF-8 Receptor Binding , 2001, Growth factors.
[150] R. Ferrell,et al. Frequent sequence variation in the human myostatin (GDF8) gene as a marker for analysis of muscle-related phenotypes. , 1999, Genomics.
[151] K. Matthews,et al. Myostatin, a transforming growth factor‐β superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct , 1999, Journal of cellular physiology.
[152] Se-Jin Lee,et al. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.
[153] V. Rosen,et al. A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. , 1999, Developmental biology.
[154] A. Joyner,et al. Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis , 1999, Mechanisms of Development.
[155] Se-Jin Lee,et al. Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[156] Se-Jin Lee,et al. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member , 1997, nature.
[157] R. Beavis,et al. Identification and Characterization of an Eight-cysteine Repeat of the Latent Transforming Growth Factor-β Binding Protein-1 that Mediates Bonding to the Latent Transforming Growth Factor-β1* , 1996, The Journal of Biological Chemistry.
[158] J. Taipale,et al. Association of the small latent transforming growth factor‐beta with an eight cysteine repeat of its binding protein LTBP‐1. , 1996, The EMBO journal.
[159] A. Maseri,et al. Age-Related Increase in Mortality among Patients with First Myocardial Infarctions Treated with Thrombolysis , 1993 .
[160] J. Massagué,et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.
[161] K. Miyazono,et al. A role of the latent TGF‐beta 1‐binding protein in the assembly and secretion of TGF‐beta 1. , 1991, The EMBO journal.
[162] A. Mason,et al. Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assembly. , 1990, Science.
[163] K. Motonishi,et al. Quantitative estimations of five classes of immunoglobulin in inbred mouse strains. , 1977, Immunology.
[164] Ji-Hyun Lee,et al. Effective RNA-silencing strategy of Lv-MSTN/GDF11 gene and its effects on the growth in shrimp, Litopenaeus vannamei. , 2015, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[165] K. Walsh,et al. Cardiometabolic effects of adiponectin. , 2014, Best practice & research. Clinical endocrinology & metabolism.
[166] H. Keutmann,et al. Heparin and activin-binding determinants in follistatin and FSTL3. , 2005, Endocrinology.